publication date: Mar. 22, 2019

In Brief

Françoise Mornex becomes first female recipient of Heine H. Hansen Award

Françoise Mornex will receive the 2019 Heine H. Hansen Award, the European Society for Medical Oncology and the International Association for the Study of Lung Cancer said. The award will be presented at the European Lung Cancer Congress, to be held  April 10–13 in Geneva.

Mornex is professor of oncology at the Université Claude Bernard in Lyon. She practices radiation and medical oncology at the Hospices Civils de Lyon. Her specialty is combined chemoradiation strategies in lung cancer, including multimodality treatment, novel chemoradiation regimens, and innovative radiotherapy techniques.

“The 2019 Heine H. Hansen Award goes to a true interpreter of the multidisciplinary approach to the diagnosis and treatment of thoracic malignancies,” Giorgio Scagliotti, IASLC president, said in a statement. “Prof. Mornex has been crucial to the success of the educational activities of both societies and has played a significant role in raising a voice about the threat of lung cancer in emerging countries.”

On receiving the honor, Mornex said: “I met Heine Hansen in 1988 when he was IASLC president. He was a charismatic, visionary leader, a pioneer in many fields, and inspired me deeply, especially with his concept of international collaboration. It is symbolic for me to receive an award with his name, reflecting the opportunity from ESMO and the IASLC to make progress in combined treatment modalities and education. Receiving this award also recognizes the scientific work of collaborative teams in Lyon, France, Europe and internationally, and supports the pivotal role of radiotherapy in the therapeutic management of lung cancer.”

Solange Peters, ESMO president-elect, said: “Needless to say, as chair of the … Continue reading Françoise Mornex becomes first female recipient of Heine H. Hansen Award

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.